IDEX (IEX) News Today

IDEX Corporation (NYSE: IEX) is receiving a modestly positive signal from analyst estimate revisions, which likely supports the stock’s recent increase. Zacks Research raised its EPS forecasts across multiple periods, including fiscal 2027 to $9.29 from $9.26 and fiscal 2028 to $10.58 from $10.54.

• Positive Sentiment: Zacks also lifted estimates for every quarterly period cited: Q1 2027 to $2.13, Q2 2027 to $2.35, Q4 2027 to $2.43, Q1 2028 to $2.39, Q2 2028 to $2.46 and Q3 2028 to $2.77. The broad-based revisions suggest slightly improved expectations for IDEX’s future earnings power.
• Neutral Sentiment: The increases were small—generally one cent per share—so the immediate effect may be limited. Investors are also weighing the revisions against IDEX’s valuation: the shares trade at roughly 33.6 times earnings, while the current-year consensus EPS estimate remains $8.83.
• Neutral Sentiment: Recent operating momentum provides context for the optimism. IDEX’s latest reported quarter exceeded earnings and revenue expectations, with revenue up 6.4% year over year, and management’s fiscal 2026 EPS guidance is $8.70–$8.85.
• Neutral Sentiment: A separate report compares IDEX with 3D Systems, but the supplied article information does not identify a specific change to IDEX’s outlook or valuation. Contrasting IDEX and 3D Systems

Overall, the upward estimate revisions are a favorable catalyst for IDEX (IEX), but their small size and the stock’s elevated earnings multiple could limit the impact unless future results show stronger growth.